Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CTLA4 anticorps

L’anticorps Lapin Chimeric anti-CTLA4 a été validé pour ELISA et in vivo. Il convient pour détecter CTLA4 dans des échantillons de Humain.
N° du produit ABIN7543362

Aperçu rapide pour Recombinant CTLA4 anticorps (ABIN7543362)

Antigène

Voir toutes CTLA4 Anticorps
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 131
  • 87
  • 44
  • 14
  • 3
Humain

Hôte

  • 74
  • 73
  • 24
  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 116
  • 67
  • 2
Chimeric

Conjugué

  • 86
  • 19
  • 13
  • 13
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CTLA4 est non-conjugé

Application

  • 101
  • 70
  • 61
  • 38
  • 28
  • 20
  • 17
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, In vivo Studies (in vivo)

Clone

5E3
  • Fonction

    Anti-CTLA-4 [5E3], Rabbit IgG, kappa

    Specificité

    The antibody is specific for CTLA-4. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    The original antibody was generated by immunizing BALB/c mice with CTLA-4 protein.

    Isotype

    IgG kappa
  • Indications d'application

    The specificity of the antibody was confirmed by ELISA analysis. The kinetic parameters of human CTLA-4 protein binding to the antibody were measured and they resulted to be at the sub-nm level. The antitumor activity of the humanized antibody was demonstrated in vivo in animal models. It was proved that the antibody inhibited the tumor in a dose-dependent manner. Mouse PD-1 antibody was combined with the antibody and used to evaluate the toxicity to mice, these experiments compared with the use of Ipilimumab in combination with PD-1 antibody. Results showed that after 5E3 antibody was used in combination with PD-1 antibody, the immunity to the body and the toxicity of heart, liver and lung are significantly lower than the toxicity of Ipilimumab in combination with PD-1 antibody (CN110343180).

    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Autre désignation

    CTLA-4

    Sujet

    Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!